Medicare open enrollment approaches as plan options, costs shift for 2027

As the annual Medicare Fall Open Enrollment (FOE) period approaches, starting October 15 and concluding December 7, beneficiaries are urged to review their current health and prescription drug coverage for 2027. This period allows individuals to make changes to their Medicare plans, such as switching between Original Medicare and Medicare Advantage, or selecting a new Part D drug plan [Medicare Rights Center]. Any changes made during this time will take effect on January 1, 2027 [Medicare Rights Center].

Recent data from the Centers for Medicare & Medicaid Services (CMS) and KFF highlight upcoming shifts in plan choices and costs. For those enrolled in standalone Medicare Part D prescription drug plans, many will see modest premium increases for 2027, with some even experiencing decreases or increases of less than 10%. However, KFF warns that some enrollees could face premium hikes of 50% or more if they do not actively switch plans [KFF Medicare]. This underscores the importance of actively comparing options each year.

Evaluating Your Coverage

Given that health plans, their costs, and individual needs can change annually, the Medicare Rights Center advises all beneficiaries to assess their options each fall [Medicare Rights Center]. This evaluation should include how well current coverage is meeting their needs, any anticipated changes to their existing Medicare Advantage (MA) or Part D plan, and a comparison with other available plans [Medicare Rights Center]. For the coming year, the average Medicare beneficiary will have access to 28 Medicare Advantage Prescription Drug Plan options [KFF Medicare].

This is also an opportune moment to check eligibility for Medicare cost-assistance programs, such as Medicare Savings Programs and Extra Help (also known as the Low-Income Subsidy) [Medicare Rights Center]. These programs can significantly reduce out-of-pocket expenses for eligible individuals.

Navigating Complexity

The process of comparing numerous plan options can be daunting for many, as plans can vary widely in terms of costs and covered services [Medicare Rights Center]. Organizations like the Medicare Rights Center note that marketing tactics can further complicate decision-making for beneficiaries [Medicare Rights Center]. Without careful review, individuals might make suboptimal choices or, in some cases, no choice at all, potentially leading to higher costs or less suitable coverage [Medicare Rights Center].

To help navigate these complexities, beneficiaries are encouraged to use available resources to understand their choices thoroughly. For example, CMS recently finalized a new mandatory drug payment model aimed at lowering drug prices for beneficiaries in Original Medicare Part B [CMS Newsroom]. Such policy changes could impact the overall landscape of drug costs and plan benefits, making a fresh look at options particularly beneficial.